University of Groningen Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine Martines, Anne-Claire
Hele tekst
(2) Chapter 7 General discussion. .
(3)
(4)
(5) ǡ
(6) Ǥ
(7)
(8) ǡ Ǥ
(9)
(10) ǡǡ ǡǦ ǡ Ǥ ǡ
(11) Ǥ . Navigating from computational metabolic model to mice to man Computational modeling of mFAO and beyond
(12) Chapter 2ǡ
(13) ǦǦ Ǥ
(14) ǡ
(15) Ǥ
(16) ǡ Ǥ Ǥ Ǧ Ǥ
(17) ǡ Ǥ
(18) ǡ ǡǯ Ǥ Ǥ
(19) Ǧ Ǥ
(20) Ǧ Ǥ ǡ ǡ ǦǤǡ ǡ Ǧ Ǧ Ǥ
(21) ǡ ͳ Ǧ ȏͳȐǤ ǡ Ǥ ȏʹȐǤ ͳ Ǥ
(22)
(23) ǡ Ǥ . Assumptions ǡ Ǥ ǡ
(24) ǡ
(25) Ǥ. ʹʹ. 7.
(26) ͽ ȟ Ǥ Ǧ Ǧ Ǥ ǡ ȏ͵ȐǤ ȏͶȐǤ ǡ Ǥ ǡ Ǥ Ǧ Ǧ DzǦǦdz ȏͷȐǤ ȏ͵Ȑ ݁. ିοீᇱబ ோ். ிு. ൌ ܭ ൌ. ௬ି మ ܸ ܭ ܭ ή ௬ି ή ி ܸ ܭ ܭ .
(27) ǦǤ ǡ ʹܪܦܣܨ݅ܭ ݈ݕܿܽ݅ܭΫ ܣܥǡ ݈ݕܿܽ݉ܭ ʹܪܦܣܨ݉ܭΫܣܥǡ ǣ ܭ ൌ. ிு ௬ି ܸ ܭ ܭ మ ή ௬ି ή ி ܸ ܭ ܭ. Ǥ ǦǤ ȟ ͲǯȋȌȏȐ
(28) ͳǦ Ǧ ͶǦ Ǧ ͲǤͲ͵͵Ǥǡ Ǥ ǡǡǯ Ǧ Ǥǡ ǯȏͷȐǤ Ǧǡ ǡ Ͷ ǯ ȏͷȐǤ
(29) ǯ ǯ
(30) ȋȽȌ ǣ ܭ ൌ. ிு ௬ି ͳ ܸ ܭ ܭ మ ή ή ௬ି ή ி ߙ ܸ ܭ ܭ. ǡ ǡ . ೝ. ͲǤ͵ͺ ͶǦ Ǧ. ǡ ͳǤͷʹ Ͷ Ǥ
(31) ǡ Ǥ ǡ ǡ Ǯ ǯ Ǥ Dzdz Ǥ α ȏ͵ǡȐǤ
(32) ǡ Ǧ ͳ ͳǦ ȏͺǡͻȐǤ ͳ Ǧ ȏͳȐǤͳǦ ͳ ͳǦ Ǧ . ʹʹͺ.
(33) ǡ Ǧ ǡ ͳȋ ͳȌǤ J (μmol.min-1.gProtein-1). 14. Published rat model Rat model w. sens. CPT1. 12. Rat model w. sens. CPT1, 2x Vcpt1. 10 8. 6 4 2 0. 0. 50. 100. [Palmitoyl-CoA]CYT ;ʅDͿ. Figure 1. Computational rat dynamic model of isolated mFAO with C16-specific CPT1 (solid lines), with C16-C4 sensitive CPT1 (dashed lines) and with C16-C4 sensitive CPT1 at twice larger Vmax (short dashed lines).. ͶǦͳͶ Ǧ ǡ ͳͶǦͳͶ Ǧ Ǥ
(34) ͳ ͶǦͳͶǤ Ǧ ͳ ǡ Ǥ ǡ ȋChapter 5Ȍ Ǧ Ǧ Ǥ Ǧ Ǧ ͳǡ Ǧ ǤChapter 5ǡ Ǧ ͳ ǦǤ Ǥ ǡ Dzdz Ǥ Ǥ ǡ Ǧ ʹ ǡ ǡ Ǥ ǡ Ǥ ǡ Ǥ ȋChapter 5ȌǤǡChapter 2 ǯ Ǥ Ǧ Chapter 2 Ǧ Ǥ ǡ ȏͳͲȐǤ
(35) ǡǡ Ǧ Ǥ Ǥ
(36) ǡ Ǧ ǡ ȋαͳͲǦȗȏǦ Ǧ ȐȌǡǦ ȋ ʹȌǤ. ʹʹͻ. 7.
(37) ͽ. J (μmol.min-1.gProtein-1). 14. Published rat model model w. ac-carn export. 12. 10 8. 6 4 2 0. 0. 50. 100. [Palmitoyl-CoA]CYT ;ʅDͿ. Figure 2. Computational rat dynamic model of isolated mFAO with (dashed lines) and without (solid lines) cytosolic acyl-carnitine export.. ǡ Ǧ Ǥ Ǧ ȏͳͳȐǤ Ǧ Ǥ ͳʹ ǡ Ǧ Ǥ
(38) ǡChapter 5ǡǦ Ǥ ǡ Ǧ ͳǦ Ǥ ǡ Ǥ ǡ Ǥ
(39) Ǧ ǡ Ǧ Ǥ Ǧ ͳǦ Ǥ ͳǤ Ǥ ǡ ͳǤǡ Ǥ
(40) Chapter ͷ
(41) Ǥ
(42) Ǧ ȋȌ Ǥ Ǧ Ǧ Ǥ ȏͳʹȐǡ ǡ ǡ ǡ ǡ ȏͳ͵ǡͳͶȐǤ Ǥ ǡ ȏͳʹǡͳ͵Ȑ ȏͳͷȐǡ Ǧ ȏͳȐǤ Ǥ
(43) Ǥ Chapter 1 and 2ǡ Ȁȋ
(44) ǡ ʹǡ ǡ Ȍ Ǥ
(45) ǡ ͷȀ ǡ ʹ͵Ͳ.
(46) ͳȋ
(47) Ȍǡ ȋǤ
(48) ǡ
(49)
(50)
(51) ǡ
(52) Ȍ ǡ ȏͳȂʹ͵ȐǤ Ǧ Ǧ Ǥ . So, what can be done to improve our understanding of the model’s behavior and to improve the accuracy of our dynamic modeling predictions? Ǥ
(53) ǡ ǡ Ǥ ǡ Ǧ ǡ ǡ Ǥ ǡ Ǧ ȏʹͶȐǤ Ǥ
(54)
(55) ǯ Ǥ
(56) Ǧ ǡ ǯǯǤ ǡ Ǧ ǡȀ ͵ǤͷǤͷȏǡʹͷȐ ǦǦ ͳͺͲȏǡǡʹͷȐǤ ʹ ȋȏǡʹȐȌǡǦǯ Ǥ
(57) Ǥ ǡ ǡ Ǥǡ ǡ Ǥ ǡ Ȃ Ȃ Ǥ ǡ Ǥ
(58) Ǧ Ǥ ǡ ǡ ǦǤ Ǥ Ǥ ǡ Ǧ ȋ
(59) Ȍ Ǥ
(60) ǡ Ǧ Ǥ Ǧ ǡ ǡ Ǧ ǡ ʹ͵ͳ. 7.
(61) ͽ ȋ ȌǤǡ Ǥ ǡ Ǧ Ǥ. Mouse models as tools to understand symptomatology in MCADD
(62) Chapter 3ǡ
(63) Ǧ Ǧ Ǧ Ǥ Ǥ ǡ Ͷ ǦȋȌȋ ȌǦ Ǥ
(64) ǡ ǦǦ ǡ
(65) Ǧ ȋȌȋ ȌǦ Ǥ ȋChapter 2ȌǦ ͳǦ ͳ ȋChapter 5ȌǤ Dzdz Ǥ ȏʹǡʹͺȐǤ ǡ ȋ Ȍ ǡ Ǥ
(66) ȏʹǡʹͺȐ ǡ ǡ Ǥ
(67) Ǥ
(68) ǡ Ǧ Ǥ
(69) ǡǦ ȋChapter 4Ȍǡ ǤǦ Ǧ Ǥ ǡ ȏʹͻǡ͵ͲȐǤ
(70) Ǧ ǤǦ ͳǦ ȋChapter 3ȌǤ
(71) Chapter 4ǡǦ Ǧǡ
(72) Ǥ ǡ
(73) Ǧ Ǥ
(74) ǡ ǡ ǡ Ǥ
(75) Ǧ ǡ ǡ Ǥ ǡ
(76) Ǧ ǡ Ǧ Ǧ Ǧ Ǥ ǦǦ Ǧ ȏ͵ͳǡ͵ʹȐ Ǧ Ǧ Ǧ Ǥǡ
(77) ǡ Ǧ Ǥ Chapter 4ǡ ʹ͵ʹ.
(78) ǡ Ǥǡǡ ǡ Ǥ
(79) ȏ͵͵ȐǤ Ǧ Ǥ . /ŶǀŝƚƌŽ cell models of human MCADD
(80) Chapter 6ǡ
(81) ǡ Ǧ Ǥ ǡ ǡ Ǥǡ Ǥ Ǧ ȋȌ ȏ͵ͶȂ͵ͻȐǤ
(82) Ǧ Ǥ
(83) ǡǡ ǡ Ǥ ǡ Ǧ ȋ Ȍǡ ͻͺͷε ȏͶͲȂͶʹȐǡ ͳͲȋ ͳͲȌ ȏͶ͵Ȑǡ Ǧ ȏͶͶȂͶȐ ȏͶͺȂͷʹȐǤ Ǧ ȋ Ȍǡ ȋ ǦǦ Ȍǡ ȋ Ȍǡ ȋ ȌǤ Ǧ Ǧ Ǥ ǡ Ǯ Ǥ Ǧǡ Ǥǡ Ǧ ʹǡ
(84) Ȁͻ ȏͷ͵Ȑ ȋǡ ǡ ǡ ȌǤ ʹ ǡ ȋ ͵ȌǤ . ʹ͵͵. 7.
(85) ͽ . A. HepG2. IHH. HUH-7. Hep3B CPT1 liver isoform CPT1 muscle isoform CPT2 VLCAD LCAD MCAD SCAD MTPa MTPb CROT MSCHAD MCKAT. . Relative cell number after 72h (% untreated control). B 150. 100. 100. 100. 50. 50. 50. Control +HoPan. *. 100. ***. 0. ***. 0. 50. 0. IHH. HepG2. 0. HUH-7. Hep3B. . C. KO. KO. KO. KO. KO. KO. KO. MCAD GAPDH. . Figure 3. Generation of an MCAD-KO hepatocyte cell line. Aǣ ʹǡ ȋ
(86) Ȍ Ǧ ͵ȋαͳȌǡ ȏͷͶȐǤ ȏͷͷȐǤ Bǣ ʹ ͷǦ Ǥ ȋ ǡǡ Ǣ ǤǤȌ ȏͷȐǤ Ǥ ǤǤǤ ά ǡ α͵Ǧ ǡ ȗδͲǤͲͷǡ ȗȗȗδͲǤͲͲͲͳ ǦǤ C: ʹ Ǥ ͵Ǧ ȋ ȌǤ ʹ ȋͷȌǤ . Ǧ ʹ ȋ Ȍ ͷȋ ͵ȌǤ Ǥ
(87) Ǧ ʹ ȋͷ ͵ȌǤ ʹ ʹΨ ǡ ͳͲΨ ȏͷȂͷͻȐǤ
(88) ǡ
(89) Ǧ ʹ. ʹ͵Ͷ.
(90) ʹΨ Ǥ ǡ Ǧ ȋȌǤ Ǧ ȋ ǤȏͲȐȌǤ Ǧ ʹ Ǥ Ǧ ǡ ǡ Ǧ ʹ Ǥ . Conclusion Ǥ ǡ ǡ Ǥ ǡ ǡ ȋȌȋ Ȍ Ǥ ȋChapter 5Ȍ ǡǤǤǦ Ǧ ʹ Ǥǡ
(91) Ǧ Ǥ ǡ Ǥ . References ͳǤ ʹǤ ͵Ǥ ͶǤ ͷǤ Ǥ Ǥ ͺǤ ͻǤ. ͳͲǤ ͳͳǤ. Ǧ ǡǡǦ ǡǤ Ǧ ͵ǦǦ Ǧ Ǧ ǦǤ ǤʹͲͳǢͳ͵ȋͶȌǣͳȂʹʹǤ Ǥ Dz dzǤ
(92) ǤʹͲͳǢͳͶȋͳʹͻȌǤ Ǥ Ǧ Ǥ
(93) Ǥ Ǥ Ǥͳͻ͵ ͺǢȋʹȌǣͳͲͶȂ͵Ǥ ǡ Ǥ ǣ ǤǤʹͲͲǢ͵Ǥ ǡ ǡǤ ǦǤ Ǥ ǤͳͻͻʹͷǢʹͷͶȋͺȌǣʹ͵ͲȂͷǤ ǡ ǡ Ǧ ǡ Ǥ Ǧ Ǥ ǤʹͲͳʹǢͶͲȋͳȌǣͲȂͷǤ Ǥ Ǥ Ǧ ǤʹͲͳ͵ǢͳͲͷȂͶʹǤ ǡ ǡ ǡǡ ǡǡ ǡ ǡǡ ǡǤ Ǧ ȾǦ ǤǤʹͲͳ͵ǢͻȋͺȌǣʹȂͻǤ ǡǦǡ ǡǡ ǡ ǡ ǡ Ǧǡ ǡ ǡ ǡ ǡ ǡǤ ǣ Ǧ ǤǤʹͲͳǢͳͶȋͳȌǣͳȂͳͷǤ ǡ ǡ ǡǡ ǡǡ ǡ ǡǡ ǡǤ Ǧ ȾǦ ǤǤʹͲͳ͵ǢͻȋͺȌǣʹȂͻǤ ǡ ǡǡ ǡǡǡ
(94) ǡ ǡ. ʹ͵ͷ. 7.
(95) ͽ. ͳʹǤ ͳ͵Ǥ ͳͶǤ ͳͷǤ ͳǤ ͳǤ. ͳͺǤ ͳͻǤ ʹͲǤ ʹͳǤ ʹʹǤ ʹ͵Ǥ ʹͶǤ ʹͷǤ ʹǤ ʹǤ ʹͺǤ ʹͻǤ. ͵ͲǤ. ͵ͳǤ. ʹ͵. ǡ Ǥ Ǧ Ǧ Ǧ ǤǤͳͻͺ͵ǢͳȋͳͳȌǣͺȂͺͶǤ ǡ ǡǡǡ ǡò ǡ Ǥǣ Ǥ ͳͲͲͲ ǤʹͲͳͷǢͶȋͲȌǣʹͳǤ ǡ ǡǡǡǡǤǣ Ǥ ǤʹͲͳʹͲǢͶͶȋͷȌǣʹͶ͵ȂͷͲǤ ǡ ǡ ǡ ǡ Ǥ Ǧ Ǥ
(96) Ǥ ʹͲͳͶǢ͵ȋͷȌǣͲͻȂͳͶǤ ǡǤǦ ǣ
(97) Ǥ ǤʹͲͳǢͳͷǣ͵ͲȂͳͻǤ ǡ ǡ ǡ ǡ ǡ ǡ Ǥ ǣ Ǧ Ǧ Ǥ Ǥ ʹͲͳͺǢͳȋͶȌǣʹͶͶȂͷͳǤ Ǧ ǡ Ǧ ǡ Ǧ ǡ Ǧ ǡ ǡ ǡ ǦǡǡǡǦ ǡǡǡ ǡ Ǧ ǡ Ǧ ǡ Ǧ ǡ Ǧ ǡ Ǥ Ǥ ȋͺͲǦȌǤʹͲͳ͵Ǣ͵ͶͲȋͳͶͲȌǣͳͷȂͲǤ ǡǡ Ǥ ȋǦ ȌǤ Ǥ ʹͲͳǢȋͳȌǣͳȂͳͶǤ ǡ ǡ ǡ ǡ Ǧ ǡ Ǧ ǡ
(98) ǡ ǡ ǡ Ǥ Ǧ
(99)
(100)
(101)
(102) ǤǤʹͲͳǢͷ͵ͻȋ͵ͲȌǣͷͻȂͺʹǤ ǡ ǡ ǡ Ǧ ǡ Ǥ ʹ Ǥ Ǥ ʹͲͳͶ ʹǢʹͲȋȌǣͳͲͻȂͷǤ ǡǡ ǡǡǡǡ ǡǡ ǡ ǡ ǡ Ǥ Ǥ ǤʹͲͳ ͳͲǢ͵ͷʹȋʹͻͳȌǣͲͳͺͻǤ ǡ
(103) ǡ Ǧ
(104) ǡ ǡ ǡ
(105) Ǥ ǡ ǡ Ǥ ǤʹͲͳǢȋͳȌǣͲǤ ǡ ǡ ǡ Ǥ Ǥ ǤʹͲͳǢʹͷȋͶȌǣͷȂǤ ǡǡ ǡ Ǥ Ǧ Ǧ ǣ Ǥ ǤʹͲͳǢͻͳȋ͵ȌǣͳͶͲͳȂ ͳʹǤ ǡ ǤǦǤ
(106) Ǥ ǤǤͳͻͺ͵ǢͳͳȋͷȌǣ͵ͳȂͺͶǤ ǡ Ǥ Ǥ ǤʹͲͲͶǢʹͲȋͳͳȌǣͳͻͷȂǤ ǡ ǡǡǡǡ
(107) Ǥ Ǧ Ǥ ǤʹͲͲͺǢͻͶȋͳȌǣͶȂͳͷǤ ǡǡǡǡ Ǥ Ǥ ǤʹͲͳͻ ʹͺǢͶȋͳȌǣͳͶͻȂͷͷǤ ǡǡǡǡǡǡǡ Ǥ ȾǦ Ǧ Ǧ Ǥ ǤʹͲͳͺǢͺȋͳȌǣͳȂͳǤ ǡǡ ǡ ǡǡ ǡ ǡ ǡ ǡ ǡ Ǥ Ǧ Ǧ Ǥ
(108) ǤʹͲͳͶǢ͵ȋͷȌǣͺ͵ȂͻǤ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ
(109) ǡ.
(110) . ͵ʹǤ ͵͵Ǥ ͵ͶǤ ͵ͷǤ ͵Ǥ ͵Ǥ ͵ͺǤ ͵ͻǤ ͶͲǤ ͶͳǤ ͶʹǤ Ͷ͵Ǥ. ͶͶǤ ͶͷǤ ͶǤ ͶǤ ͶͺǤ ͶͻǤ ͷͲǤ. ͷͳǤ ͷʹǤ ͷ͵Ǥ. ǡ ǡǡǡ ǡ ǡ ǡ ǡ Ǥ.
(111) Ǧ ǤǤʹͲͳǢʹȋ͵ȌǣͷͲͻȂͷʹʹǤǤ Ǥ ǤǤʹͲͳǢʹȋ͵ȌǣͶͷͶȂͷǤ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ ǡ Ǥ Ǥ ǤʹͲͳǢͷͷͳȋͺȌǣͳͳͷȂͺǤ ǡ ǡ Ǥ
(112) ǤǤʹͲͳͺǢͳͲǣͳȂ͵ͺǤ ǡ
(113) ǡ ǤǦ͵Ǥ ǤʹͲͳǢʹ͵ȋͷȌǣ͵ͻ͵ȂͶͳͲǤ ǡ ǡǡǦǤ Ǥ ǤʹͲͳǢͳͶͶȋȌǣͻ͵ͺȂͶͳǤ ǡǡǡǤǦǣ Ǥ ǤʹͲͳͺǢȋͶȌǣʹͶ͵ȂͷǤ ǡǤǦǦǦ ǣ Ǥ ǤʹͲͳͻǢͲͲȋͲͲȌǤ ǡǡǡǡǡ ǡǤǮ Ǥǯ ǤʹͲͳͺǢ͵͵ȋͳȌǣͳͷȂʹͷǤ Ǥ Ǧ Ǧ ȋȌ ǤʹͲͳͶǤ Ǥ ͻͺͷε ȋ͵ͲͶȌ ȏ
(114) ȐǤ ʹͲͳ ȏ ʹͲͳͻ ʹͳȐǤ ǣ ǣȀȀ ǤȀ ʹȀȀȀͲͳͺͺͳͻͺͶ ǡ ǡ ǡ Ǥ
(115) Ǥ ǤʹͲͳǢͷͺȋͷȌǣͻͷͷȂͳǤ ǡǡǡǡ ǡ Ǥ ͳͲ͵ǣ Ǥ ǤʹͲͳͷǢʹͻͲȋͶȌǣʹͶȂ Ǥ ǡ ǡ ǡ ǡ ǡ Ǥ Ǧ Ǧ Ǥ
(116) ǤʹͲͳ͵Ǣ͵ȋȌǣͻ͵ȂͺͳǤ ǡ ǡ Ǥ ʹǤǤʹͲͳͺǢͺȋͳȌǣͳȂͳͲǤ ǡ ǡ ǡ ǡ ǡ Ǥ Ǥ
(117) Ǥ ʹͲͳͲǢ͵͵ȋͷȌǣͷͷͷȂͳǤ ǤǦǣ ǫ
(118) ǤʹͲͲ͵ǢʹȋʹȂ͵ȌǣͳͺͳȂͺǤ ǡǡǡǡǡ ǡǡ æǡ ǡ ǡ Ǥ ͶǯǦ ǤǤʹͲͳͷǢͳͳȋȌǣͳȂʹǤ ǡǡǡ ǡǡ ǡǡ Ǥ Ǥ Ǥ ʹͲͳͺǢͻȋͳȌǤ
(119) ǡǡǡǡ ǡ ǡ ǡǡ ǡǡǡ ǡǡǡ ǡ,ǡ ǡ ǡ ǡ ǡǡǤ ǦͶǯǦ Ǥ ǤʹͲͳ ͳʹǢȋͳȌǣͳͳʹͲǤ ǡ ǡǡǡǡ
(120) Ǥ Ǧ Ǥ ǤʹͲͲͺǢͻͶȋͳȌǣͶȂͳͷǤ ǡǡǡǡ Ǥ Ǥ ǤʹͲͳͻǢͶȋͳȌǣͳͶͻȂͷͷǤ ǡ ǡ ǡǡ ǡ Ǥ
(121) Ǧ. ʹ͵. 7.
(122) ͽ. ͷͶǤ. ͷͷǤ ͷǤ ͷǤ ͷͺǤ ͷͻǤ ͲǤ. ʹ͵ͺ. ͻǤ ǤʹͲͳ͵ǢͺȋͳͳȌǣʹʹͺͳȂ͵ͲͺǤ ǡ ǡ ǡ Ǧ ǡ ǡ ǡ ǡ ǡ ǡ Ǥ Ǥ Ǥ ʹͲͳǢͳͷȋͻȌǣ͵ʹͲͶȂͳ͵Ǥ ǡ ǡǡǤ᩿ǣ ǤʹͲͲͻǢ͵ȋȌǣͷʹȂͲǤ ǡ ǡ ǡ ǡ ǡ ǡ Ǥ
(123) Ǥ Ǥ ʹͲͳʹ ͳͷǢʹͲ͵ȋͳȌǣͻȂǤ. ǡ ǡǡ Ǥ
(124) ǣ ʹ ǤǤʹͲͳǢͷȋʹͶȌǣͳȂͳʹǤ ǡǡ ǡǡǡǡǡ ǡ ǡ ǡ Ǥ Ǥ ǤʹͲͳͺ͵ǢͺȋͳȌǣͳͳͺͷǤ ǡǡ ¡ ǡǡǤ ʹ Ǥ ǦǤʹͲͳǢͳͺͳȋͳȌǣͷͳȂͻǤ ǡǡǡ ǡ
(125) ǡ ǡ ǡǡǤ
(126) ǣ ǡ Ǥ ǤʹͲͳʹǢͳͳͺȋ ȌǣͳͲʹȂͳͳǤ.
(127)
(128)
(129)
GERELATEERDE DOCUMENTEN
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of
Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine: from computational model to mice to man..
Exploring the mechanisms underlying the phenotype of MCAD deficiency with Systems Medicine Martines, Anne-Claire.. IMPORTANT NOTE: You are advised to consult the publisher's
B Published model No prom CPT2 No prom VLCAD No prom LCAD No prom MCAD No prom SCAD No prom CROT No prom MSCHAD No prom MCKAT No prom MTP No promiscuity.. Published
HF Fe ͳǤͲ ͷǤͳ ͳǤ͵ ͲǤͲ ͷǤ͵ ͵Ǥͺ ͳǤͶ ͳǤͻ ͲǤͺ ͵Ǥ ͶǤͲ ͲǤͲ ʹǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͳǤͺ ʹǤʹ ʹǤͳ ͲǤͲ ʹǤ͵ ͲǤͲ ͲǤ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ Ǥͳ ͵ǤͶ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ͲǤͲ ʹǤͲ ͲǤͲ ͲǤͲ ͷǤͳ
ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͳ ʹǤͳ ͲǤͷ ͳǤ͵ͳ ͲǤͲ ͲǤͲͳ ͲǤͲͲ ͲǤͲͳ ͲǤͲʹ ͲǤͲͳ ͲǤͲʹ ͲǤͲͳ ͲǤͲͳ ͲǤͲͳ ͲǤͲ͵ ͲǤͲͶ ͲǤͲͶ ͲǤͲ ͲǤͲͳ ͲǤͲͷ ͲǤͲʹ ͲǤͲͳ ͲǤͲͳ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ ͲǤͲͲ
Flux control coefficients of model with ACS knockdown to 1% of its reference value JNAD production JCPT1C16 [CoASH]MAT [palmitoyl-CoA]CYT ʹͷɊ ͳͲͲɊ ʹͷɊ ͳͲͲɊ ʹͷɊ ͳͲͲɊ
of Pediatrics, Center of Liver, Digestive and Metabolic Diseases, University of Groningen, Groningen, University Medical Center Groningen, Groningen, The Netherlands, 2 Department